ZP OPCO INC has a total of 15 patent applications. It decreased the IP activity by 83.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and surface technology and coating are CHEN YANBIAO, ISIFER AB and ADAPT PHARMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Surface technology and coating |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Syringes | |
#3 | Therapeutic chemical compounds | |
#4 | Processes for applying fluent materials |
# | Name | Total Patents |
---|---|---|
#1 | Ao Yi | 14 |
#2 | Daddona Peter E | 12 |
#3 | Ameri Mahmoud | 12 |
#4 | Kellerman Donald | 5 |
#5 | Mahmoud Ameri | 2 |
#6 | Kellerman Danald | 2 |
#7 | Vargas Matt | 1 |
#8 | Schmidt Peter C | 1 |
#9 | Lee Vivian | 1 |
#10 | Heasley Jessica | 1 |
Publication | Filing date | Title |
---|---|---|
US2020000712A1 | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches | |
US2019070103A1 | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches | |
CN111050749A | Method for rapidly achieving therapeutic concentrations of zolmitriptan for the treatment of migraine and cluster headache | |
WO2017143345A1 | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines | |
WO2017079611A1 | Stable glucagon peptide formulations | |
US2016051467A1 | Stable glucagon peptide formulations | |
US2015057605A1 | Stable glucagon peptide formulations | |
EP3027263A1 | Low-profile microneedle patch applicator |